AusPAR: Rituximab
Australian Public Assessment Report
Device/Product Name
MabThera
Active ingredients
Rituximab
AusPAR Date
Published
Sponsor
Submission Number
PM-2009-01744-3-3
Submission Type
Extension of indications, Broaden patient population